MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
IEEE Spectrum
June 2012
Samuel K. Moore
Electromagnetic Depression Treatment Nears Approval Deep transcranial magnetic stimulation adds to psychiatry's arsenal of electronic remedies mark for My Articles similar articles
IEEE Spectrum
March 2006
Samuel K. Moore
Psychiatry's Shocking New Tools Electronic implants and electromagnetic pulses are picking up where psychoactive drugs have failed. mark for My Articles similar articles
IEEE Spectrum
May 2005
Samuel K. Moore
Zapping Away The Blues Cyberonics Inc. plans to introduce the first implanted device that can treat a psychiatric illness. mark for My Articles similar articles
The Motley Fool
February 4, 2005
Stephen D. Simpson
Cyberonics' Depression Zapper Medical technology company gets a much-needed boost from the FDA. mark for My Articles similar articles
BusinessWeek
May 2, 2005
Kate Murphy
Easing Depression Without Drugs Doctors are trying therapies, from implants to herbs, that can cut down on side effects. mark for My Articles similar articles
The Motley Fool
June 16, 2004
W.D. Crotty
Nothing Depressing Cyberonics Cyberonics Gets FDA nod; shareholder Boston Scientific gets a portfolio boost. mark for My Articles similar articles
Fast Company
April 2004
Scott Kirsner
Fantastic Voyage Cyberonics' medical implant is the size of a chocolate-chip cookie, and it could be worth $2.8 billion someday. But as this dramatic tale of innovation and entrepreneurship shows, saving lives can be one tough business. mark for My Articles similar articles
Fast Company
November 2004
Scott Kirsner
A Slow, Patient Pace A follow-up to a recent story on a pacemaker that helps patients with epilepsy and seeks additional approval for patients who suffer from severe, drug-resistant depression -- including comments from the parents of a six-year-old epileptic who is using the device. mark for My Articles similar articles
The Motley Fool
July 12, 2011
Arundhati Parmar
FDA Allows Expansion of St. Jude Study to Treat Severe Depression St. Jude moves forward with treatment for depression. mark for My Articles similar articles
The Motley Fool
December 31, 2010
Brian Orelli
2010 FDA Approvals and a Look Ahead Recent history can help us handicap FDA decisions. mark for My Articles similar articles
BusinessWeek
March 7, 2005
Michael Arndt
Rewiring The Body First came pacemakers. Now exotic implants are bringing new hope to victims of epilepsy, paralysis, depression, and other diseases. And some of the biggest names in health care are in a scramble to get into the market. mark for My Articles similar articles
The Motley Fool
February 8, 2005
Stephen D. Simpson
Cyberonics Looks to the Future Shifting resources to the launch of a depression therapy will hurt now, but should pay off later. Investors looking to take on some risk in exchange for an aggressive growth opportunity might want to explore this one. mark for My Articles similar articles
The Motley Fool
February 16, 2010
Brian Orelli
For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward. mark for My Articles similar articles
American Family Physician
January 1, 2006
Rupke, Blecke & Renfrow
Cognitive Therapy for Depression Family physicians usually are the first to diagnose and treat patients with depression. They should inform patients that psychotherapy and pharmacotherapy are valid options, and that cognitive therapy is the most studied psychotherapy. mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2014
Jill Wechsler
Compassionate Use Requests Complicate Drug Development Pharma, HCPs, and regulators walk tightrope in addressing early-access push while supporting biomedical R&D. mark for My Articles similar articles
Nursing
April 2008
Kathryn Murphy
Shedding the burden of depression & anxiety Learn about types of depression and available treatments. mark for My Articles similar articles
The Motley Fool
November 22, 2005
Stephen D. Simpson
Cyberonics' Ride Not Over Yet One way or another, this medical device maker's stock is almost certain to produce more volatility in the years to come. mark for My Articles similar articles
Pharmaceutical Executive
December 1, 2013
FDA Pursues Delicate Balancing Act The Agency struggles to ensure access to needed medicines while minimizing potential risks, writes Jill Wechsler. mark for My Articles similar articles
Pharmaceutical Executive
March 1, 2012
Ron Cohen
FDA's Necessary Dose of Reality There's no fast-acting salve, but there are several steps that can be taken to streamline many of the procedures at FDA. And it begins with leadership. mark for My Articles similar articles
American Family Physician
November 1, 2006
Lurie et al.
Seasonal Affective Disorder Patients with seasonal affective disorder have episodes of major depression that tend to recur during specific times of the year, usually in winter. Like major depression, seasonal affective disorder probably is underdiagnosed in primary care settings. mark for My Articles similar articles
Wired
July 24, 2007
Melinda Wenner
A Few Transcranial Zaps and You're a Happy Genius A new technique called transcranial magnetic stimulation may let neuroscientists listen to the conversations between cells in your brain. mark for My Articles similar articles
The Motley Fool
October 10, 2005
Stephen D. Simpson
The FDA: Boon, Bane, Whipping Boy Everyone wants the FDA to be faster, better, and cheaper, but that may not be a credible expectation. Investors would do well to keep an eye on the FDA because its policies and pressures ultimately filter down to our medicine cabinets, wallets, and portfolios. mark for My Articles similar articles
Pharmaceutical Executive
April 1, 2006
Jill Wechsler
Washington Report: A Warning Trend Washington's new answer to drug safety concerns is more warnings and more disclosure of undigested data. But warnings can go too far. Haven't FDA's critics ever heard the story of the boy who cried wolf? mark for My Articles similar articles
IndustryWeek
October 19, 2011
FDA: A Future Innovation Partner? Could the Food and Drug Administration reform itself to help manufacturers create new medical technologies? mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2007
Clinton & Wechsler
The View From Inside Commissioner Andrew von Eschenbach on drug safety, DTC advertising, FDA's culture, and how the agency plans to bring itself into the age of molecular medicine. mark for My Articles similar articles
Pharmaceutical Executive
December 1, 2006
Richard A. Epstein
FDA vs. the Individual In this excerpt from his important new book Overdose, an ever controversial legal scholar argues that the current system overvalues risk, ignores individual differences, and deprives patients of valuable treatments. mark for My Articles similar articles
American Family Physician
September 15, 2002
Depression What is depression?... What causes depression?... How is depression diagnosed?... How is depression treated?... What about suicide?... mark for My Articles similar articles